Prof. Yuanfang Li 李元方
Chief Physician, Professor
Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Clinical diagnosis and treatment of gastric cancer, pancreatic cancer, and soft tissue tumors, with a focus on comprehensive therapy for gastric cancer.
Dr. Li earned a bachelor's degree from Sun Yat-sen University of Medical Sciences (1995–2000) and has worked at Sun Yat-sen University Cancer Center since 2000. Dr. Li completed master's and doctoral degrees while working (2007–2012).
Name order: in Chinese the family name comes first (Li Yuanfang). Papers usually list the name as Yuanfang Li or Li Y.
Selected publications
94 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Med, 2026 (senior author): Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial. PubMed 42600610
- Cell Rep Med, 2025 (senior author): Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer. PubMed 40532664
- Gut, 2025 (first author): CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. PubMed 39537239
- Drug Resist Updat, 2024 (first author): Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers. PubMed 38219532
- J Natl Cancer Inst, 2023 (first author): Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials. PubMed 37389446
- World J Oncol, 2022 (first author): Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma. PubMed 35837321
- Ann Surg Oncol, 2022 (senior author): Correction to: Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis. PubMed 34873658
- Ann Surg Oncol, 2022 (senior author): Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis. PubMed 34796431
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion